$Case series: rituximab in the treatment of refractory sight-threatening scleritis$

Case series: rituximab in the treatment of refractory sight-threatening scleritis

Bibliographic Details
Main Authors:	van Bilsen Kiki, van Hagen P, Missotten Tom, Baarsma Seerp G, Kuijpers Robert W, van Laar Jan AM
Format:	Article
Language:	English
Published:	BMC 2011-11-01
Series:	Journal of Translational Medicine

Similar Items

Commentary: Rituximab in scleritis
by: Parthopratim Dutta Majumder
Published: (2020-01-01)

Combined Infliximab and Rituximab in Necrotising Scleritis
by: Jiten Morarji, et al.
Published: (2012-09-01)

Rituximab for non-infectious Uveitis and Scleritis
by: Caleb C. Ng, et al.
Published: (2021-08-01)

Tofacitinib for refractory uveitis and scleritis
by: Michael A. Paley, et al.
Published: (2019-03-01)

Management of necrotizing scleritis after pterygium surgery with rituximab
by: Tania Sales de Alencar Fidelix, et al.

Rituximab therapy combined with methotrexate for severe necrotizing scleritis in a case of granulomatosis with polyangiitis
by: Somasheila I Murthy, et al.
Published: (2020-01-01)

New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy
by: Claudia Fabiani, et al.
Published: (2020-01-01)

Worsening of posterior scleritis and orbital pseudotumor in a patient with granulomatosis polyangiitis with rituximab-A case report
by: Kalpana Babu, et al.
Published: (2020-01-01)

Sight-threatening Diabetic Retinopathy in a Swedish County – : Prevalence and Comparison of Patients with and without Sight-threatening Diabetic Retinopathy
by: Gustafsson, Sebastian
Published: (2017)

Utilization of Rituximab for Refractory Rowell Syndrome
by: Sukhraj Singh, et al.
Published: (2021-01-01)

Rituximab for refractory granulomatous eye disease
by: Lower EE, et al.
Published: (2012-10-01)

The Prevalence of Undiagnosed Age-Related Sight-Threatening Diseases in Self-Proclaimed Healthy Individuals
by: Sophie Lemmens, et al.
Published: (2020-01-01)

Rituximabe na síndrome de Felty refratária Rituximab in the refractory Felty's syndrome
by: Thiago Sotero Fragoso, et al.
Published: (2009-04-01)

Efficacy and safety of rituximab biosimilar in refractory lupus
by: Nantakarn Pongtarakulpanit, et al.
Published: (2020-12-01)

Rituximab in the treatment of refractory lupus nephritis with vasculitis
by: Huseyin Kadikoy, et al.
Published: (2012-01-01)

Early management of sight threatening retinopathy in incontinentia pigmenti
by: Sarah Michel, et al.
Published: (2020-08-01)

Sight-threatening optic neuropathy is associated with paranasal lymphoma
by: Takahiko Hayashi, et al.
Published: (2010-03-01)

Preventing sight-threatening ROP: a neonatologist’s perspective
by: Ashok Deorari, et al.
Published: (2017-11-01)

Pseudomonas aeruginosa scleritis initially presenting as idiopathic diffuse anterior scleritis
by: Shweta Agarwal, et al.
Published: (2020-01-01)

RITUXIMAB: NEW RESOURCES OF MANAGEMENT OF SEVERE REFRACTORY JUVENILE RHEUMATOID ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2008-04-01)

RITUXIMAB: NEW RESOURCES OF MANAGEMENT OF SEVERE REFRACTORY JUVENILE RHEUMATOID ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2008-01-01)

Scleritis and sclerokeratitis associated with IgA vasculitis: A case series
by: I. Hernanz, et al.
Published: (2021-06-01)

Thermography in posterior scleritis
by: A. Kawali, et al.
Published: (2020-11-01)

Rituximab: a novel treatment for refractory Riedel’s thyroiditis
by: Leanne Hunt, et al.
Published: (2018-02-01)

Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
by: J Dretzke, et al.
Published: (2010-10-01)

Successful treatment with rituximab of refractory immune thrombocytopenic purpura
by: Daniela Tirotta, et al.
Published: (2009-12-01)

Preventing sight-threatening ROP: the role of nurses in reducing the risk
by: Ana Quiroga, et al.
Published: (2017-11-01)

Myopia: a growing global problem with sight-threatening complications
by: Brien A Holden, et al.
Published: (2015-09-01)

Combined tenonplasty and scleral graft for refractory Pseudomonas scleritis following pterygium removal with mitomycin C application
by: Heidar Siatiri, et al.
Published: (2018-01-01)

Somatostatin receptor scintigraphy in sarcoidosis
by: Kamphuis Lieke SJ, et al.
Published: (2011-11-01)

Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus
by: Fabio Bonilla-Abadía, et al.
Published: (2014-01-01)

Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
by: Fernando Henrique Carlos de Souza, et al.
Published: (2018-09-01)

Refractory myasthenia gravis – clinical profile, comorbidities and response to rituximab
by: Sudulagunta, Sreenivasa Rao, et al.
Published: (2016-10-01)

Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL
by: James D’Rozario, et al.
Published: (2019-05-01)

Remission Achieved in Refractory Advanced Takayasu Arteritis Using Rituximab
by: D. Ernst, et al.
Published: (2012-01-01)

Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis
by: Wee Leng Gan, et al.
Published: (2018-10-01)

Successful treatment of refractory adult onset Still’s disease with rituximab
by: N. Belfeki, et al.
Published: (2016-12-01)

Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare
by: Emmanuel Ribeiro, et al.
Published: (2009-01-01)

Mycobacterium aurum keratitis: an unusual etiology of a sight-threatening infection
by: Behnam Honarvar, et al.

Mycobacterium aurum keratitis: An unusual etiology of a sight-threatening infection
by: Behnam Honarvar, et al.
Published: (2012-03-01)